Partner | Life Sciences
100 Kimball Drive
David, managing partner of Deloitte Tax’s Life Sciences practice, has nearly 30 years of experience working with clients on a variety of corporate tax planning strategies in the pharmaceutical, medical device, and biotechnology sectors. David’s experience includes advising clients on new healthcare legislation, medical device excise tax, mergers, acquisitions and divestitures, joint ventures and strategic alliances, tax-aligned supply chain restructuring, and tax credits and incentives.
Six months into tax reform, what do life sciences and health care companies intend to do with the savings?